ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Period	Debt/Equity
2015-12-31	0.78
2016-12-31	0.90
2017-12-31	1.36
2018-12-31	1.18
2019-12-31	1.15
2020-12-31	1.36
2021-12-31	1.15
2022-12-31	1.25
2023-12-31	0.98
2024-12-31	2.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ANIP	$78.58	-1.11%	0.48M
3
4
5

ANI Pharmaceuticals Inc. (ANIP) Debt to Equity Ratio

Debt to Equity Ratio Data

Get ANI Pharmaceuticals Inc. Data in Excel

More ANIP Financial Data